Recap: BioLife Solns Q4 Earnings

BioLife Solns BLFS reported its Q4 earnings results on Thursday, February 29, 2024 at 04:00 PM.

Here's what investors need to know about the announcement.

BioLife Solns beat estimated earnings by 38.0%, reporting an EPS of $-0.21 versus an estimate of $-0.34.

Revenue was down $11.53 million from the same period last year.

Last quarter the company beat on EPS by $0.05 which was followed by a 4.0% drop in the share price the next day.

Here's a look at BioLife Solns's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.38	-0.20	-0.21	-0.17
EPS Actual	-0.33	-0.24	-0.27	-0.19
Revenue Estimate	32.94M	43.86M	42.94M	43.28M
Revenue Actual	33.33M	39.51M	37.70M	44.26M

To track all earnings releases for BioLife Solns visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar